flashContent
Company news

18 May 2017

Alkor Bio Group has participated in CMEF 2017 in Shanghai

Alkor Bio Group, one of the Russian leading manufacturers of reagent kits for laboratory in vitro diagnostics, has participated in the 77th China International Medical Equipment Fair (CMEF Spring 2017) event was held May 15-18 in Shanghai.

11 May 2017

Alkor Bio Group has obtained the registration certificates for the tumor markers ELISA kits in Uzbekistan

At the beginning of May 3 ELISA kits produced by Alkor Bio has obtained The Ministry of Health of the Republic of Uzbekistan registration certificates. These kits are intended for diagnostics and monitoring of treatment of cancer.  

10 April 2017

Alkor Bio Group has participated in the No.1 Trade India’s Fair for hospitals, health centers and clinics “Medical Fair India”

Alkor Bio Group, one of the Russian leading manufacturers of reagent kits for laboratory in vitro diagnostics, has participated in the India’s 23rd International Exhibition and Conference was held April 6-8 in New Delhi. More than 500 participants from 20 countries were presented their products.

29 March 2017

Alkor Bio Group has developed 13 new allergens for in vitro allergy diagnostics

At the beginning of March Laboratory of Allergology has transferred to the production 12 new allergens, including 5 food allergens, 3 moulds, 4 different allergens from epithelia, trees, weeds and other allergens groups and 1 weed mix.

 

23 March 2017

Two new laboratories: chemical and microbiology were established by Alkor Bio Group in 2016

The microbiology laboratory began working in early December after licensing for carrying out activities in using of human & animal pathogens of infectious diseases and genetically modified organisms, the 3rd and 4th degrees of potential danger, in closed systems.

15 February 2017

"Trans-Technologies" Ltd (a part of «Alkor Bio» Group) receives European patent "Biotransplant for cellular therapy based on mesenchymal bone marrow stem сells"

9th November 2016 the European Patent Office granted the patent "Biotransplant for cellular therapy based on mesenchymal bone marrow stem сells for "Trans-Technologies" Ltd (Alkor Bio Group of Companies)". The patent application describes derivation of culture of human mesenchymal stem cells from bone marrow and using them for production of corresponding biotransplant. The invention refers to the field of cellular therapy and tissue engineering and may potentially be used, for instance, in treatment of various ischaemic diseases. The invention considered new indeed, that is especially remarkable due to the tough competition in the human stem cell research field in European Union.